RACGP speaks up at misconduct management inquiry Any new laws must ‘strike the right balance’ when it comes to the management of professional misconduct, the college President told Queensland Parliament.
Prescriptions for most popular statins on the rise Data shows the number of people using the most popular statins is increasing, while the cost for COVID-19 antivirals has fallen.
Registered nurses’ prescribing powers expanded Nurses who have undergone extra training will soon be able to work to a broader scope of practice under a new prescriber arrangement.
Health ministers must better link hospitals and GPs: RACGP The college used the year’s final Health Ministers’ Meeting to call out the lack of integration, saying it is delaying care.
‘A focus on innovation and reform’: NHRA Review revealed Fragmentation dangers, lack of long-term vision, and never-ending red tape – those were the problems laid bare by a probe of the agreement.
Australian Prescriber makes its comeback The publication, which had an uncertain future following funding cuts to its previous publisher NPS MedicineWise, is going out to readers once again.
Stop the use of named hospital referrals: RACGP The proposal is among a suite of reforms put forward by the college in its submission to a review of the National Health Reform Agreement.
Wider eligibility for Paxlovid announced From 1 April the availability of the oral antiviral on the PBS will expand to include over-60s with only one risk factor for severe disease.
In Practice: New infection control resource The RACGP has released its fifth edition guidelines for infection prevention and control in general practices.
‘A positive step’: oral antivirals confirmed for Doctor’s Bag After extensive RACGP lobbying, GPs now have enhanced access to COVID-19 oral antiviral treatments for urgent use among at-risk patients.